Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Peptide Antibiotics Market?

In recent times, the peptide antibiotics market has witnessed substantial growth. Its size is set to escalate from $5.25 billion in 2024 to $5.82 billion in 2025, at a compound annual growth rate (CAGR) of 10.8%. The noteworthy expansion during the historic period can be credited to the discovery and progression of peptide antibiotics, a hike in antibiotic resistance, a surge in the occurrence of infectious diseases, advancements in peptide synthesis technology, and the growth of the pharmaceutical industry.

What Growth Rate Is Forecasted for the Peptide Antibiotics Market by 2029?

Anticipations show a significant surge in the peptide antibiotics market, as it is proposed to expand to $8.47 billion by 2029, with a compound annual growth rate (CAGR) of 9.8%. Numerous factors contribute to this notable growth expected within the forecast period, such as a heightened emphasis on the creation of innovative antibiotics, the rising global occurrence of antibiotic-resistant infections, the expansion of research and development in antimicrobial peptides, and regulatory support for the approval of new antibiotics. Key trends that are expected to shape the forecast period include searching for antimicrobial peptides in natural resources, applying peptide antibiotics for the health of animals, enhancing efficacy through peptide engineering, developing combination peptide antibiotics, as well as incorporating artificial intelligence and machine learning in the discovery of peptide antibiotics.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7780&type=smp

Which Key Companies Are Shaping the Future of the Peptide Antibiotics Market?

Major companies operating in the peptide antibiotics market include Eli Lilly and Company, GlaxoSmithKline plc, Novartis AG, Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Sandoz International GmbH, Xellia APS, Johnson & Johnson Inc., AstraZeneca PLC, Bayer AG, Bristol-Myers Squibb Company, Lupin Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Wockhardt Ltd., Zydus Lifesciences Limited, Alkem Laboratories Limited, Allecra Therapeutics GmbH, Antabio, Basilea Pharmaceutica Ltd., BioVersys AG

Which Factors Are Driving Demand in the Peptide Antibiotics Industry?

The rise in the occurrence of various infectious ailments is predicted to fuel the peptide antibiotics market’s expansion. Infectious diseases, which are caused by damaging microorganisms like bacteria, fungi, parasites and more, have seen a surge due to factors such as rapid urbanization, climate fluctuation, increased potential for disease emergence and more. This has led to a higher demand for peptide antibiotics, which function by breaking down the cell membranes, thus underlining their antibacterial effectiveness. For instance, the World Health Organization, a Switzerland-based international body, reported in May 2024 that there were already more than seven million dengue cases in the American region by April 2024, a notably higher figure compared to the 4.6 million total cases in 2023. Hence, the rise in infectious diseases serves as a key driver for the growth of the peptide antibiotics market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=7780&type=smp

How Is the Peptide Antibiotics Market Segmented by Several Divisions?

The peptide antibiotics market covered in this report is segmented –

1) By Type: Ribosomal Synthesized Peptide Antibiotics, Non-Ribosomal Synthesized Peptide Antibiotics

2) By Drugs: Daptomycin, Dalbavancin, Telavancin, Other Drugs

3) By Disease Outlook: Skin Infection, HABP Or VABP, Blood Stream Infection, Other Diseases

4) By Distribution Channel: Hospitals, Homecare, Specialty Clinics, Other Distribution Channels

Subsegments:

1) By Ribosomal Synthesized Peptide Antibiotics: Aminoglycosides, Macrolides, Tetracyclines, Lincosamides

2) By Non-Ribosomal Synthesized Peptide Antibiotics: Bacitracins, Vancomycin, Polymyxins, Cyclic Lipopeptides

What are the Emerging Market Trends Driving the Growth of the Peptide Antibiotics Industry?

A key trend that’s emerging in the peptide antibiotics market is the establishment of strategic partnerships. To broaden their market reach and take advantage of mutual resources, major firms in this market are initiating collaborations. For example, Berkeley Lights, a leading American digital cell biology firm, joined forces with Aanika Biosciences in January 2022. Under this agreement, Aanika will utilize Berkeley Lights’ advanced, high-throughput functional screening services to swiftly locate and enhance functional antimicrobial peptides (AMPs) effective against harmful bacteria, especially ones responsible for foodborne diseases. Moreover, they will employ the Beacon Optofluidic Platform to pinpoint peptides posing harm to bacteria in order to create a unique antibacterial tag. The tag will subsequently be utilized within their bacterial spore-based barcoding system to safeguard the food supply chain. Aanika Biosciences is an American biotechnology firm.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/peptide-antibiotics-global-market-report

Which Regions Are Driving Growth in the Peptide Antibiotics Market?

North America was the largest region in the peptide antibiotics market in 2024. The regions covered in the peptide antibiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7780

This Report Delivers Insight On:

1. How big is the peptide antibiotics market, and how is it changing globally?

2. Who are the major companies in the peptide antibiotics market, and how are they performing?

3. What are the key opportunities and risks in the peptide antibiotics market right now?

4. Which products or customer segments are growing the most in the peptide antibiotics market?

5. What factors are helping or slowing down the growth of the peptide antibiotics market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model